CD147 is highly expressed in human epidermal growth factor receptor 2 (HER2)-positive breast cancer tissues, and its suppression enhances the anticancer efficacy of trastuzumab by increasing apoptosis in breast cancer cells [81]. The gene discussed is ERBB2; the disease is breast cancer.